Ebba Biotech AB was founded in 2016 by professor Agneta Richter-Dahlfors to enable commercial applications and more widespread use of fluorescent tracer (optotracers) molecules. Ebba Biotech produces, sells and delivers the many variants of purpose-built fluorescent tracer (optotracer) molecules to research laboratories, hospitals and industry worldwide.
Optotracing is an innovative fluorescent visualization method developed by scientists for use in fluorescence microscopy and spectroscopy. The optotracing technology has been developed by a scientific expert team of researchers at Karolinska Institutet, Linköping University and the Royal Institute of Technology (KTH) in Sweden and is a result of many years of cutting-edge nanoscience and organic chemistry research.
Ebba Biotech has commercialized distribution and sales of optotracer molecules and today supply these in three different series: